Common Contracts
11 similar Subscription Agreement contracts
ContractSubscription Agreement • May 31st, 2023
Q3-2023 - SUBSCRIPTION AGREEMENT Valid until further notice 1 Parties 1.1 Medicortex Finland Oyj (Plc), a corporation duly organized and validly existing under the laws of Finland with its business identity code 2625992-6 (the “Company”), focusing on research and development of pharma products and diagnostic kits; and 1.2 Name: Date of birth (dd/mm/yyyy): Citizen of *: Personal identity code *: (the entirety above will be later called “Subscriber”) * Domicile and Corporate registration code in case an entity or organization is subscrib- ing. In addition, a document proving the signatory right of the entity is needed (such as excerpt from the national trade registry). 2 Recitals The Company is authorized to issue to the Subscriber the Shares, which shall have the rights, preferences, privileges and restrictions set forth in this Agreement and the Articles of Association of the Company (the “Transaction Documents”). The Subscriber has agreed to su
November-2023 - SUBSCRIPTION AGREEMENTSubscription Agreement • May 31st, 2023
Valid through 14 to 28 November 2023 1 Parties 1.1 Medicortex Finland Oyj (Plc), a corporation duly organized and validly existing under the laws of Finland with its business identity code 2625992-6 (the “Company”), focusing on research and development of pharma products and diagnostic kits; and 1.2 Name: Date of birth (dd/mm/yyyy): Citizen of *: Personal identity code *: (the entirety above will be later called “Subscriber”) * Domicile and Corporate registration code in case an entity or organization is subscrib- ing. In addition, a document proving the signatory right of the entity is needed (such as excerpt from the national trade registry). 2 Recitals The Company is authorized to issue to the Subscriber the Shares, which shall have the rights, preferences, privileges and restrictions set forth in this Agreement and the Articles of Association of the Company (the “Transaction Documents”). The Subscriber has agreed to subscribe the Shares subject t
ContractSubscription Agreement • May 31st, 2023
Q4-2024 - SUBSCRIPTION AGREEMENT Valid until further notice 1 Parties 1.1 Medicortex Finland Oyj (Plc), a corporation duly organized and validly existing under the laws of Finland with its business identity code 2625992-6 (the “Company”), focusing on research and development of pharma products and diagnostic kits; and 1.2 Name: Date of birth (dd/mm/yyyy): Citizen of *: Personal identity code *: (the entirety above will be later called “Subscriber”) * Domicile and Corporate registration code in case an entity or organization is subscrib- ing. In addition, a document proving the signatory right of the entity is needed (such as excerpt from the national trade registry). 2 Recitals The Company is authorized to issue to the Subscriber the Shares, which shall have the rights, preferences, privileges and restrictions set forth in this Agreement and the Articles of Association of the Company (the “Transaction Documents”). The Subscriber has agreed to su
ContractSubscription Agreement • May 31st, 2023
Q2-2024 - SUBSCRIPTION AGREEMENT Valid until further notice 1 Parties 1.1 Medicortex Finland Oyj (Plc), a corporation duly organized and validly existing under the laws of Finland with its business identity code 2625992-6 (the “Company”), focusing on research and development of pharma products and diagnostic kits; and 1.2 Name: Date of birth (dd/mm/yyyy): Citizen of *: Personal identity code *: (the entirety above will be later called “Subscriber”) * Domicile and Corporate registration code in case an entity or organization is subscrib- ing. In addition, a document proving the signatory right of the entity is needed (such as excerpt from the national trade registry). 2 Recitals The Company is authorized to issue to the Subscriber the Shares, which shall have the rights, preferences, privileges and restrictions set forth in this Agreement and the Articles of Association of the Company (the “Transaction Documents”). The Subscriber has agreed to su
ContractSubscription Agreement • May 31st, 2023
Q1-2024 - SUBSCRIPTION AGREEMENT Valid until further notice 1 Parties 1.1 Medicortex Finland Oyj (Plc), a corporation duly organized and validly existing under the laws of Finland with its business identity code 2625992-6 (the “Company”), focusing on research and development of pharma products and diagnostic kits; and 1.2 Name: Date of birth (dd/mm/yyyy): Citizen of *: Personal identity code *: (the entirety above will be later called “Subscriber”) * Domicile and Corporate registration code in case an entity or organization is subscrib- ing. In addition, a document proving the signatory right of the entity is needed (such as excerpt from the national trade registry). 2 Recitals The Company is authorized to issue to the Subscriber the Shares, which shall have the rights, preferences, privileges and restrictions set forth in this Agreement and the Articles of Association of the Company (the “Transaction Documents”). The Subscriber has agreed to su
ContractSubscription Agreement • May 31st, 2023
Q4-2023 - SUBSCRIPTION AGREEMENT Valid until further notice 1 Parties 1.1 Medicortex Finland Oyj (Plc), a corporation duly organized and validly existing under the laws of Finland with its business identity code 2625992-6 (the “Company”), focusing on research and development of pharma products and diagnostic kits; and 1.2 Name: Date of birth (dd/mm/yyyy): Citizen of *: Personal identity code *: (the entirety above will be later called “Subscriber”) * Domicile and Corporate registration code in case an entity or organization is subscrib- ing. In addition, a document proving the signatory right of the entity is needed (such as excerpt from the national trade registry). 2 Recitals The Company is authorized to issue to the Subscriber the Shares, which shall have the rights, preferences, privileges and restrictions set forth in this Agreement and the Articles of Association of the Company (the “Transaction Documents”). The Subscriber has agreed to su
ContractSubscription Agreement • May 31st, 2023
Q2-2023 - SUBSCRIPTION AGREEMENT Valid until further notice 1 Parties 1.1 Medicortex Finland Oyj (Plc), a corporation duly organized and validly existing under the laws of Finland with its business identity code 2625992-6 (the “Company”), focusing on research and development of pharma products and diagnostic kits; and 1.2 Name: Date of birth (dd/mm/yyyy): Citizen of *: Personal identity code *: (the entirety above will be later called “Subscriber”) * Domicile and Corporate registration code in case an entity or organization is subscrib- ing. In addition, a document proving the signatory right of the entity is needed (such as excerpt from the national trade registry). 2 Recitals The Company is authorized to issue to the Subscriber the Shares, which shall have the rights, preferences, privileges and restrictions set forth in this Agreement and the Articles of Association of the Company (the “Transaction Documents”). The Subscriber has agreed to su
ContractSubscription Agreement • May 31st, 2023
Q3-2024 - SUBSCRIPTION AGREEMENT Valid until further notice 1 Parties 1.1 Medicortex Finland Oyj (Plc), a corporation duly organized and validly existing under the laws of Finland with its business identity code 2625992-6 (the “Company”), focusing on research and development of pharma products and diagnostic kits; and 1.2 Name: Date of birth (dd/mm/yyyy): Citizen of *: Personal identity code *: (the entirety above will be later called “Subscriber”) * Domicile and Corporate registration code in case an entity or organization is subscrib- ing. In addition, a document proving the signatory right of the entity is needed (such as excerpt from the national trade registry). 2 Recitals The Company is authorized to issue to the Subscriber the Shares, which shall have the rights, preferences, privileges and restrictions set forth in this Agreement and the Articles of Association of the Company (the “Transaction Documents”). The Subscriber has agreed to su
ContractSubscription Agreement • January 25th, 2023
Q1-2023 - SUBSCRIPTION AGREEMENT Valid until further notice 1 Parties 1.1 Medicortex Finland Oyj (Plc), a corporation duly organized and validly existing under the laws of Finland with its business identity code 2625992-6 (the “Company”), focuses on research and development of pharma products and diagnostic kits; and, 1.2 Name: Date of birth (dd/mm/yyyy): Citizen of *: Personal identity code*: (the entirety above will be later called “Subscriber”) * Domicile and Corporate registration code in case a company or organization is sub- scribing. In addition, a document proving the signatory of the entity is needed (such as excerpt from the national trade registry). 2 Recitals The Company is authorized to issue to the Subscriber the Shares, which shall have the rights, preferences, privileges and restrictions set forth in this Agreement and the Articles of Association of the Company (the “Transaction Documents”). The Subscriber has agreed to s
ContractSubscription Agreement • December 16th, 2022
Q1-2023 - SUBSCRIPTION AGREEMENT Valid until 20 January 2023 1 Parties 1.1 Medicortex Finland Oyj (Plc), a corporation duly organized and validly existing under the laws of Finland with its business identity code 2625992-6 (the “Company”) which focuses on research and development of pharma products and diagnostic kits. and 1.2 Name: Date of birth (dd/mm/yyyy): Citizen of *: Personal identity code*: (the “Sub- scriber”) * Domicile and Corporate registration code in case a company or organization is sub- scribing. In addition, a document proving the signatory of the entity is needed (such as excerpt from the national trade registry). 2 Recitals The Company is authorized to issue to the Subscriber the Shares, which shall have the rights, preferences, privileges and restrictions set forth in this Agreement and the Articles of Association of the Company (the “Transaction Documents”). The Subscriber has agreed to subscribe the Shares subject to the te
Q3-2022 - SUBSCRIPTION AGREEMENTSubscription Agreement • September 7th, 2022
